The Enterprise Value as of December 2025 (TTM) for China National Medicines Corporation Ltd. (600511.SS) is 16.74B

According to China National Medicines Corporation Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 16.74B. This represents a change of 10.08% compared to the average of 15.21B of the last 4 quarters.

China National Medicines Corporation Ltd. (600511.SS) Historical Enterprise Value (quarterly & annually)

How has 600511.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of China National Medicines Corporation Ltd. over the last ten years is 17.24B. The current 16.74B Enterprise Value has changed 9.61% with respect to the historical average. Over the past ten years (40 quarters), 600511.SS's Enterprise Value was at its highest in in the December 2020 quarter at 31.78B. The Enterprise Value was at its lowest in in the June 2016 quarter at 11.70B.

China National Medicines Corporation Ltd. (600511.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of China National Medicines Corporation Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

China National Medicines Corporation Ltd. (600511.SS) Average Enterprise Value

How has 600511.SS Enterprise Value performed in the past?

The current Enterprise Value of China National Medicines Corporation Ltd. (600511.SS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

China National Medicines Corporation Ltd. (600511.SS) Enterprise Value vs. Peers

How is 600511.SS’s Enterprise Value compared to its peers?

China National Medicines Corporation Ltd.’s Enterprise Value is less than Hubei Jumpcan Pharmaceutical Co., Ltd. (21.35B), greater than Joincare Pharmaceutical Group Industry Co.,Ltd. (14.20B), less than Tasly Pharmaceutical Group Co., Ltd (21.14B), less than China Resources Double-Crane Pharmaceutical Co.,Ltd. (18.14B), less than Jilin Aodong Pharmaceutical Group Co., Ltd. (23.50B), less than Jiangsu Nhwa Pharmaceutical Co., Ltd. (23.41B), less than ApicHope Pharmaceutical Co., Ltd (22.63B), less than Betta Pharmaceuticals Co., Ltd. (22.15B), less than Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (25.26B), less than Autobio Diagnostics Co., Ltd. (20.50B),

Build a custom stock screener for China National Medicines Corporation Ltd. (600511.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like China National Medicines Corporation Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

China National Medicines Corporation Ltd. (600511.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like China National Medicines Corporation Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.